Singapore: Ampio Pharmaceuticals has taken its candidate NCE001 from its proprietary methylphenidate derivatives family ...
Singapore: The US FDA Cardiovascular and Renal Drugs Advisory Committee has disapproved Japan-based Otsuka Pharmaceutic...
Singapore: Global pharmaceutical company, Pfizer, and Japanese firm, Kyowa Hakko Kirin, are jointly assessing the therap...
Singapore: The Network Verification Challenge has generated a comprehensive set of biological models relevant to chroni...
Singapore: Australia-based Prana Biotechnology has achieved positive result in its phase II clinical trial investigating...
Singapore: Novartis has partnered with Global Alliance for TB Drug Development (TB Alliance) for compounds to fight tube...
Singapore: China's ShangPharma appointed Dr Art Taveras as president and chief scientific officer (CSO). He will be resp...
Singapore: Professor John Wong Eu-Li, currently chief executive of National University Health System (NUHS), Isabel Chan...
Singapore: Taiwan based TWi Pharmaceuticals has received US FDA and Taiwan FDA approval of a protocol for a Phase II cli...
Singapore: Japan's Ono Pharmaceutical and Kyowa Hakko Kirin has partnered with Bristol-Myers Squibbs for Phase 1 clinica...
Singapore: Novartis has acquired the license for exclusive right to use Antibody-Drug Conjugate (ADC) technology from ...
Singapore: BioBusiness Asia concluded in Taiwan on July 18, 2013, with a message that the global biotech fraternity need...
Singapore: National Health Innovation Centre (NHIC) of Singapore has partnered with global pharmaceutical company, Astra...
Singapore: Japan's Chugai Pharmaceutical filed an application with the Japanese Ministry of Health, Labour and Welfare, ...
Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Japan's Sumitomo Mitsui Banking Corporat...
Singapore: The Mainland Affairs Council (MAC) recently announced that Taiwan and China have reached a concrete consensus...
Singapore: European Commission has approved Eliquis (apixaban) for prevention of stroke and systemic embolism in adult p...
Singapore: Eli Lilly and Company completed its phase III study regarding stage IV metastatic squamous non-small cell lun...
